Dr. Don Jarvis

Revoredo, L., Clausen, H, Moremen, K.W., Jarvis, D.L., Ten Hagen, K.G., Tabak, L.A., and Gerken, T.A. 2016. Mucin type O-glycosylation is controlled and ordered by short and long range glycopeptide substrate recognition that varies among members of the polypeptide GalNAc transferase (ppGalNAc-T) family. Glycobiology 26:360-376. PMC4767052.

Maghodia, A.B., Geisler, C., and Jarvis, D.L. 2016. Characterization of an Sf-rhabdovirus-negative S. frugiperda cell line as an alternative host for recombinant protein production in the baculovirus-insect cell system. Prot. Expr. Purif. 122:45-55. PMC4842140.

Geisler, C. and Jarvis, D.L. 2016. Rhabdovirus-like endogenous viral elements in the genome of Spodoptera frugiperda insect cells are actively transcribed: implications for adventitious virus detection. Biologicals 44:219-225. PMC4939140.

Rico, A. Phillips, A.T., Schountz, T, Jarvis, D.L., Tjalkens, R.B., Powers, A.M. and Olson, K.E. 2016. Venezuelan and western equine encephalitis virus E1 liposome antigen nucleic acid complexes protect mice from lethal challenge with multiple alphaviruses. Virology 499:30-39. PMC5884135.

Mabashi-Asazuma, H. and Jarvis, D.L. 2017. CRISPR-Cas vectors for genome editing and host engineering in the baculovirus-insect cell system. Proc. Nat’l. Acad. Sci. U.S.A. 114:9068-9073. PMC5576809.

Maghodia, A.B. and Jarvis, D.L. 2017. Infectivity of Sf-rhabdovirus variants in insect and mammalian cell lines. Virology 512:234-245. PMC5651996.

Moremen K.W., Ramiah A., Stuart M., Steel, J., Meng, L., Forouhar, F., Moniz, H.A., Gahlay, G., Gao, Z., Chapla, D., Wang, S., Yang, J.-Y., Prabhakar, P.K., Johnson, R., de la Rosa, M., Geisler, C., Nairn, A.V., Wu, S.-C., Tong, L., Gilbert, H.J., LaBaer, J., and Jarvis, D.L. 2018. Expression system for structural and functional studies of human glycosylation enzymes. Nat. Chem. Biol. 14:156-162. PMC5774587.

Maghodia, A.B., Geisler, C., and Jarvis, D.L. 2020. A new Nodavirus-negative T. ni cell line for baculovirus-mediated protein production. Biotechnol. Bioengr. 117:3248-3264.

Nonaka, M., Suzuki-Anekoji, M., Nakayama, J., Mabashi-Azuma, H., Jarvis, D.L., Yeh, J.-C., Akama, T.O., Huang, C.-T., Rosa Compos, A., Nagaoka, M., Nishizawa, C., Shibata, T.K., Sugihara, K., Fukuda, M., and Fukuda, M.N. Chun-Teng. 2020. Overcoming the blood–brain barrier by annexin A1-binding peptide to target brain tumours. Br. J. Cancer 123:1633–164. PMC7686308.

Fukuda, M.N., Nonaka, M., Mabashi-Asazuma, H., Jarvis, D.L., Yamasaki, K., Akama, T., Nagaoka, M., Sasai, T., Kimura-Takagi, I., Suwa, Y., Yaegashi, T., Huang, C.-T., and Nishizawa-Harada, C. 2021. Development of an orally-administrable tumor vasculature-targeting therapeutic using annexin A1-binding D-peptides. PLoS One 16:e0241157. PMC7787448.

Maghodia, A.B., Geisler, C., and Jarvis, D.L. 2021. A new bacmid for customized glycosylation pathway engineering in the baculovirus-insect cell system. ACS Chem. Biol. doi: 10.1021/acschembio.0c00974. Online ahead of print.